Additionally, while we propose potential mechanisms underlying the differential effects of APOE and DAOA genotypes in AD-EOAD, our study lacks the direct molecular or neuropathological data necessary to confirm these hypotheses. The gene discussed is APOE; the disease is Alzheimer disease.